$BRO

Brown & Brown 3Q 2026: Revenue $1.73B, EPS $0.67— 10-Q Summary

Brown & Brown reported 3Q 2026 revenue of $1.73B, up 7.4% YoY, with net income rising 5.7% to $240M. EPS was $0.67, down 1.5% YoY. Growth driven by commissions, fees, and acquisitions, with retail organic revenue up 2.6% and specialty distribution down 0.8%.

Original reporting
Published Oct 26, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Brown & Brown 3Q 2026: Revenue $1.73B, EPS $0.67— 10-Q Summary — source image
Decision brief

The 30-second read

$BROBullishHigh
01

Why it matters

The earnings release shows solid top‑line growth and stable EPS, suggesting resilience in underwriting and successful integration of recent acquisitions.

02

Market read

First‑report earnings for a mid‑cap insurer; likely to influence broker‑distribution stocks and the broader insurance sector.

03

What to watch

Potential headwinds from European capability investments and specialty distribution decline could temper upside.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Brown & Brown is a publicly traded insurance brokerage (ticker BRO) that filed its Q3 2026 10‑Q on Oct 26, 2026.

Company-level read

Ticker impact

$BROBullishHigh confidence
Context

Brown & Brown reported Q3 2026 revenue of $1.73B and EPS $0.67, a fresh earnings disclosure with YoY growth.

Expected impact

potential upside as the market prices in the revenue beat and stable EPS

Evidence & confidence

First‑report earnings numbers for a mid‑cap insurer; revenue growth and stable margins suggest better‑than‑expected performance.

Market effects

Insurance sector may see modest lift as Brown & Brown demonstrates organic growth and acquisition momentum.

U.S. market participants may adjust exposure to property‑casualty insurers.

Limited; primarily U.S. insurance investors.

Counterpoint

If the market had already priced in the acquisition‑driven growth, the earnings may disappoint on organic performance.

Key entities

  • Brown & Brown

    Insurance brokerage reporting Q3 2026 results.

Related articles

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.

$BROMed

Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.

$BROMed

Why Brown & Brown (BRO) stock is trading lower today

Brown & Brown (BRO) shares fell 4.9% after reporting Q3 2026 revenue of $1.73B, up 7.4% YoY, but with slowing organic growth and margin compression. CEO Powell Brown noted declines in excess-and-surplus property rates and expected further decreases in 2027. The stock is down 13.4% YTD, trading at $67.25, 23.4% below its 52-week high.